Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sanofi SA

52.32
-1.2200-2.28%
Pre-market: 52.510.1900+0.36%05:22 EDT
Volume:5.49M
Turnover:288.52M
Market Cap:128.08B
PE:19.19
High:52.92
Open:52.86
Low:52.23
Close:53.54
Loading ...

Kymera Provides Pipeline Objectives for 2025, Stock Gains

Zacks
·
16 Jan

Sanofi: Information concerning the total number of voting rights and shares – November 2024

GlobeNewswire
·
16 Jan

SNY's Subcutaneous Sarclisa Proves Non-Inferior to IV Formulation (Revised)

Zacks
·
14 Jan

Regeneron Stock Plunges 35.6% in Six Months: Fold or Hold?

Zacks
·
13 Jan

SNY's Subcutaneous Sarclisa Outperforms IV Formulation in Cancer Study

Zacks
·
10 Jan

DNLI's Hunter Syndrome Drug Gets Breakthrough Therapy Designation

Zacks
·
10 Jan

Sanofi's Blood Cancer Drug's New Subcutaneous Formulation Hits Primary Goal In Late-Stage In Multiple Myeloma

Benzinga
·
09 Jan

Denali's ALS Study Fails to Meet Primary and Secondary Endpoints

Zacks
·
08 Jan

Why Vaccine Stocks, Lucid (LCID) Are Rallying

Insider Monkey
·
07 Jan

Sanofi Down 10% in 3 Months: How Should You Play the Stock?

Zacks
·
07 Jan

AstraZeneca Stock Down Almost 14% in 3 Months: Time to Sell?

Zacks
·
06 Jan

PFE, BMY, SNY, and Others Are Set to Raise Prices on 250 Drugs

TIPRANKS
·
01 Jan

Market Chatter: Drug Companies to Raise Prices on 250 Branded Drugs in 2025

MT Newswires Live
·
31 Dec 2024

The Zacks Analyst Blog Highlights ServiceNow, AMD, Sanofi, Team and United-Guardian

Zacks
·
24 Dec 2024

Why Teva Pharmaceuticals Industries (TEVA) Skyrocketed?

Insider Monkey
·
24 Dec 2024

Top Research Reports for ServiceNow, AMD & Sanofi

Zacks
·
24 Dec 2024

Why Is Sanofi (SNY) Among the Best European Dividend Stocks To Buy Now?

Insider Monkey
·
24 Dec 2024

Sanofi's 21-Valent Pneumococcal Vaccine Enters Phase III

Zacks
·
24 Dec 2024

Sanofi’s Tolebrutinib Receives FDA Breakthrough Therapy Designation for nrSPMS

TipRanks
·
21 Dec 2024

Pharma Stock Roundup: PFE's 2025 Outlook, MRK & ABBV's M&A Deals

Zacks
·
20 Dec 2024